{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:19:38Z","timestamp":1794262778995,"version":"4.9.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82103347"],"award-info":[{"award-number":["82103347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32570067"],"award-info":[{"award-number":["32570067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32500048"],"award-info":[{"award-number":["32500048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00914-y","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:05:17Z","timestamp":1775901917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NK-cell-derived exosomes exert antitumor potency via miR-140\/XYLT1\/HSPG2 axis"],"prefix":"10.1186","volume":"31","author":[{"given":"Dingru","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiquan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-dong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"914_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"914_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3322\/caac.21596","volume":"70","author":"LB Kennedy","year":"2020","unstructured":"Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70:86\u2013104. https:\/\/doi.org\/10.3322\/caac.21596.","journal-title":"CA Cancer J Clin"},{"key":"914_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, et al. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22:40. https:\/\/doi.org\/10.1186\/s12943-023-01740-y.","journal-title":"Mol Cancer"},{"key":"914_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jconrel.2023.11.003","volume":"364","author":"J Chen","year":"2023","unstructured":"Chen J, Zhang G, Wan Y, et al. Immune cell-derived exosomes as promising tools for cancer therapy. J Control Release. 2023;364:508\u201328. https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.003.","journal-title":"J Control Release"},{"key":"914_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01278-3","volume":"19","author":"Z Xu","year":"2020","unstructured":"Xu Z, Zeng S, Gong Z, et al. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol Cancer. 2020;19:160. https:\/\/doi.org\/10.1186\/s12943-020-01278-3.","journal-title":"Mol Cancer"},{"key":"914_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.canlet.2021.02.023","volume":"506","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shi T, Song X, et al. Gene fusion neoantigens: emerging targets for cancer immunotherapy. Cancer Lett. 2021;506:45\u201354. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.023.","journal-title":"Cancer Lett"},{"key":"914_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"key":"914_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00431-5","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Tian L, Lu J, et al. Exosomes and cancer-diagnostic and prognostic biomarkers and therapeutic vehicle. Oncogenesis. 2022;11:54. https:\/\/doi.org\/10.1038\/s41389-022-00431-5.","journal-title":"Oncogenesis"},{"key":"914_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4.","journal-title":"Signal Transduct Target Ther"},{"key":"914_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"GJ Goodall","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21:22\u201336. https:\/\/doi.org\/10.1038\/s41568-020-00306-0.","journal-title":"Nat Rev Cancer"},{"key":"914_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00975-3","volume":"7","author":"B Chen","year":"2022","unstructured":"Chen B, Dragomir MP, Yang C, et al. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther. 2022;7:121. https:\/\/doi.org\/10.1038\/s41392-022-00975-3.","journal-title":"Signal Transduct Target Ther"},{"key":"914_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, et al. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024;25:211\u201332. https:\/\/doi.org\/10.1038\/s41576-023-00662-1.","journal-title":"Nat Rev Genet"},{"key":"914_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082380","author":"D Li","year":"2021","unstructured":"Li D, Gao C, Kuang M, et al. Nanoparticles as drug delivery systems of RNAi in cancer therapy. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26082380.","journal-title":"Molecules"},{"key":"914_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, et al. Noncoding RNA therapeutics-challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629\u201351. https:\/\/doi.org\/10.1038\/s41573-021-00219-z.","journal-title":"Nat Rev Drug Discov"},{"key":"914_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/gt.2017.8","volume":"24","author":"L Jiang","year":"2017","unstructured":"Jiang L, Vader P, Schiffelers RM. Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy. Gene Ther. 2017;24:157\u201366. https:\/\/doi.org\/10.1038\/gt.2017.8.","journal-title":"Gene Ther"},{"key":"914_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174435","author":"H Kim","year":"2021","unstructured":"Kim H, Jang H, Cho H, et al. Recent advances in exosome-based drug delivery for cancer therapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13174435.","journal-title":"Cancers (Basel)"},{"key":"914_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9:27. https:\/\/doi.org\/10.1038\/s41392-024-01735-1.","journal-title":"Signal Transduct Target Ther"},{"key":"914_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02045-4","volume":"23","author":"C Si","year":"2024","unstructured":"Si C, Gao J, Ma X. Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications. Mol Cancer. 2024;23:134. https:\/\/doi.org\/10.1186\/s12943-024-02045-4.","journal-title":"Mol Cancer"},{"key":"914_CR19","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.7150\/thno.18752","volume":"7","author":"L Zhu","year":"2017","unstructured":"Zhu L, Kalimuthu S, Gangadaran P, et al. Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics. 2017;7:2732\u201345. https:\/\/doi.org\/10.7150\/thno.18752.","journal-title":"Theranostics"},{"key":"914_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1158\/0008-5472.CAN-18-0779","volume":"79","author":"P Neviani","year":"2019","unstructured":"Neviani P, Wise PM, Murtadha M, et al. Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms. Cancer Res. 2019;79:1151\u201364. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0779.","journal-title":"Cancer Res"},{"key":"914_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139. https:\/\/doi.org\/10.1038\/nmeth.1923.","journal-title":"Nat Methods"},{"key":"914_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedlander","year":"2012","unstructured":"Friedlander MR, Mackowiak SD, Li N, et al. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012;40:37\u201352. https:\/\/doi.org\/10.1093\/nar\/gkr688.","journal-title":"Nucleic Acids Res"},{"key":"914_CR23","doi-asserted-by":"publisher","first-page":"12023","DOI":"10.1073\/pnas.0500053102","volume":"102","author":"K Nakahara","year":"2005","unstructured":"Nakahara K, Kim K, Sciulli C, et al. Targets of microRNA regulation in the Drosophila oocyte proteome. Proc Natl Acad Sci USA. 2005;102:12023\u20138. https:\/\/doi.org\/10.1073\/pnas.0500053102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"914_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-5-1-r1","volume":"5","author":"AJ Enright","year":"2003","unstructured":"Enright AJ, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol. 2003;5:R1. https:\/\/doi.org\/10.1186\/gb-2003-5-1-r1.","journal-title":"Genome Biol"},{"key":"914_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332407","author":"S Jiang","year":"2024","unstructured":"Jiang S, Cai M, Li D, et al. Association of breast milk-derived arachidonic acid-induced infant gut dysbiosis with the onset of atopic dermatitis. Gut. 2024. https:\/\/doi.org\/10.1136\/gutjnl-2024-332407.","journal-title":"Gut"},{"key":"914_CR26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656.","journal-title":"Bioinformatics"},{"key":"914_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innovation"},{"key":"914_CR28","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA\u2013ceRNA, miRNA\u2013ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92-97. https:\/\/doi.org\/10.1093\/nar\/gkt1248.","journal-title":"Nucleic Acids Res"},{"key":"914_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5199572","volume":"2022","author":"MY Cai","year":"2022","unstructured":"Cai MY, Yip CY, Pan K, et al. Role of carbon monoxide in oxidative stress-induced senescence in human bronchial epithelium. Oxid Med Cell Longev. 2022;2022:5199572. https:\/\/doi.org\/10.1155\/2022\/5199572.","journal-title":"Oxid Med Cell Longev"},{"key":"914_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00805-y","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li M, Chen L, et al. Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct Target Ther. 2021;6:409. https:\/\/doi.org\/10.1038\/s41392-021-00805-y.","journal-title":"Signal Transduct Target Ther"},{"key":"914_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156481","volume":"175","author":"F Ma","year":"2024","unstructured":"Ma F, Wang X, Qiu Z, et al. NK-derived exosome miR-1249-3p inhibits Mycobacterium tuberculosis survival in macrophages by targeting SKOR1. Cytokine. 2024;175:156481. https:\/\/doi.org\/10.1016\/j.cyto.2023.156481.","journal-title":"Cytokine"},{"key":"914_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01787-4","volume":"17","author":"D Li","year":"2020","unstructured":"Li D, Wang Y, Jin X, et al. NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice. J Neuroinflammation. 2020;17:126. https:\/\/doi.org\/10.1186\/s12974-020-01787-4.","journal-title":"J Neuroinflammation"},{"key":"914_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-020-00207-w","volume":"26","author":"L Wang","year":"2020","unstructured":"Wang L, Wang Y, Quan J. Exosomal miR-223 derived from natural killer cells inhibits hepatic stellate cell activation by suppressing autophagy. Mol Med. 2020;26:81. https:\/\/doi.org\/10.1186\/s10020-020-00207-w.","journal-title":"Mol Med"},{"key":"914_CR34","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.76319","author":"SG Dosil","year":"2022","unstructured":"Dosil SG, Lopez-Cobo S, Rodriguez-Galan A, et al. Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses. Elife. 2022. https:\/\/doi.org\/10.7554\/eLife.76319.","journal-title":"Elife"},{"key":"914_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2221081","volume":"12","author":"AL Di Pace","year":"2023","unstructured":"Di Pace AL, Pelosi A, Fiore PF, et al. MicroRNA analysis of natural killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells. Oncoimmunology. 2023;12:2221081. https:\/\/doi.org\/10.1080\/2162402X.2023.2221081.","journal-title":"Oncoimmunology"},{"key":"914_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188672","volume":"1877","author":"KF Pan","year":"2022","unstructured":"Pan KF, Yang YC, Lee WJ, et al. Proteoglycan Endocan: a multifaceted therapeutic target in cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188672. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188672.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"914_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113668","volume":"43","author":"BB Johnson","year":"2024","unstructured":"Johnson BB, Cosson MV, Tsansizi LI, et al. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. Cell Rep. 2024;43:113668. https:\/\/doi.org\/10.1016\/j.celrep.2023.113668.","journal-title":"Cell Rep"},{"key":"914_CR38","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1182\/blood.2023022736","volume":"143","author":"RT Piszczatowski","year":"2024","unstructured":"Piszczatowski RT, Bulow HE, Steidl U. Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis. Blood. 2024;143:2571\u201387. https:\/\/doi.org\/10.1182\/blood.2023022736.","journal-title":"Blood"},{"key":"914_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ccell.2023.11.008","volume":"42","author":"A Sreekumar","year":"2024","unstructured":"Sreekumar A, Lu M, Choudhury B, et al. B3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signaling. Cancer Cell. 2024;42:52-69 e57. https:\/\/doi.org\/10.1016\/j.ccell.2023.11.008.","journal-title":"Cancer Cell"},{"key":"914_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/CJI.0000000000000179","volume":"40","author":"A Shoae-Hassani","year":"2017","unstructured":"Shoae-Hassani A, Hamidieh AA, Behfar M, et al. NK cell-derived exosomes from NK cells previously exposed to neuroblastoma cells augment the antitumor activity of cytokine-activated NK cells. J Immunother. 2017;40:265\u201376. https:\/\/doi.org\/10.1097\/CJI.0000000000000179.","journal-title":"J Immunother"},{"key":"914_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.10.034","volume":"190-191","author":"L Zhu","year":"2019","unstructured":"Zhu L, Kalimuthu S, Oh JM, et al. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming. Biomaterials. 2019;190\u2013191:38\u201350. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.10.034.","journal-title":"Biomaterials"},{"key":"914_CR42","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/10430349950018030","volume":"10","author":"YK Tam","year":"1999","unstructured":"Tam YK, Maki G, Miyagawa B, et al. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum Gene Ther. 1999;10:1359\u201373. https:\/\/doi.org\/10.1089\/10430349950018030.","journal-title":"Hum Gene Ther"},{"key":"914_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16962","volume":"9","author":"IY Kim","year":"2023","unstructured":"Kim IY, Kim HY, Song HW, et al. Functional enhancement of exosomes derived from NK cells by IL-15 and IL-21 synergy against hepatocellular carcinoma cells: the cytotoxicity and apoptosis in vitro study. Heliyon. 2023;9:e16962. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16962.","journal-title":"Heliyon"},{"key":"914_CR44","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41417-021-00352-2","volume":"29","author":"Y Enomoto","year":"2022","unstructured":"Enomoto Y, Li P, Jenkins LM, et al. Cytokine-enhanced cytolytic activity of exosomes from NK cells. Cancer Gene Ther. 2022;29:734\u201349. https:\/\/doi.org\/10.1038\/s41417-021-00352-2.","journal-title":"Cancer Gene Ther"},{"key":"914_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2019.01.007","volume":"446","author":"H Huang","year":"2019","unstructured":"Huang H, Wang Y, Li Q, et al. miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9. Cancer Lett. 2019;446:81\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.007.","journal-title":"Cancer Lett"},{"key":"914_CR46","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/tox.24026","volume":"39","author":"M Yu","year":"2024","unstructured":"Yu M, Fan Y, Zhao Y, et al. MicroRNA-140-3p inhibits proliferation and promotes apoptosis in non-small cell lung cancer by targeting MDIG. Environ Toxicol. 2024;39:1521\u201330. https:\/\/doi.org\/10.1002\/tox.24026.","journal-title":"Environ Toxicol"},{"key":"914_CR47","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1080\/21655979.2022.2036910","volume":"13","author":"D Wei","year":"2022","unstructured":"Wei D, Zeng J, Rong F, et al. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5). Bioengineered. 2022;13:5126\u201340. https:\/\/doi.org\/10.1080\/21655979.2022.2036910.","journal-title":"Bioengineered"},{"key":"914_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-020-00036-3","volume":"45","author":"J Wang","year":"2020","unstructured":"Wang J, Zhu M, Zhou X, et al. MiR-140-3p inhibits natural killer cytotoxicity to human ovarian cancer via targeting MAPK1. J Biosci. 2020;45:66.","journal-title":"J Biosci"},{"key":"914_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.str.2018.03.014","volume":"26","author":"DC Briggs","year":"2018","unstructured":"Briggs DC, Hohenester E. Structural basis for the initiation of glycosaminoglycan biosynthesis by human xylosyltransferase 1. Structure. 2018;26:801-809 e803. https:\/\/doi.org\/10.1016\/j.str.2018.03.014.","journal-title":"Structure"},{"key":"914_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","volume":"42","author":"RV Iozzo","year":"2015","unstructured":"Iozzo RV, Schaefer L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 2015;42:11\u201355. https:\/\/doi.org\/10.1016\/j.matbio.2015.02.003.","journal-title":"Matrix Biol"},{"key":"914_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1021\/acs.molpharmaceut.0c00839","volume":"18","author":"M Kalita","year":"2021","unstructured":"Kalita M, Villanueva-Meyer J, Ohkawa Y, et al. Synthesis and screening of alpha-xylosides in human glioblastoma cells. Mol Pharm. 2021;18:451\u201360. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00839.","journal-title":"Mol Pharm"},{"key":"914_CR52","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrc1649","volume":"5","author":"MM Fuster","year":"2005","unstructured":"Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005;5:526\u201342. https:\/\/doi.org\/10.1038\/nrc1649.","journal-title":"Nat Rev Cancer"},{"key":"914_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143495","author":"W Zhang","year":"2022","unstructured":"Zhang W, Lin Z, Shi F, et al. HSPG2 mutation association with immune checkpoint inhibitor outcome in melanoma and non-small cell lung cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14143495.","journal-title":"Cancers (Basel)"},{"key":"914_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-cellbio-100109-104126","volume":"26","author":"JR Couchman","year":"2010","unstructured":"Couchman JR. Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol. 2010;26:89\u2013114. https:\/\/doi.org\/10.1146\/annurev-cellbio-100109-104126.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"914_CR55","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/brain\/awn206","volume":"131","author":"A Hurtado","year":"2008","unstructured":"Hurtado A, Podinin H, Oudega M, et al. Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord. Brain. 2008;131:2596\u2013605. https:\/\/doi.org\/10.1093\/brain\/awn206.","journal-title":"Brain"},{"key":"914_CR56","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.122.063481","volume":"147","author":"C Gollmann-Tepekoylu","year":"2023","unstructured":"Gollmann-Tepekoylu C, Graber M, Hirsch J, et al. Toll-Like Receptor 3 mediates aortic stenosis through a conserved mechanism of calcification. Circulation. 2023;147:1518\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.063481.","journal-title":"Circulation"},{"key":"914_CR57","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajhg.2014.01.020","volume":"94","author":"C Bui","year":"2014","unstructured":"Bui C, Huber C, Tuysuz B, et al. XYLT1 mutations in Desbuquois dysplasia type 2. Am J Hum Genet. 2014;94:405\u201314. https:\/\/doi.org\/10.1016\/j.ajhg.2014.01.020.","journal-title":"Am J Hum Genet"},{"key":"914_CR58","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.4049\/jimmunol.1302079","volume":"191","author":"M Brusilovsky","year":"2013","unstructured":"Brusilovsky M, Cordoba M, Rosental B, et al. Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses. J Immunol. 2013;191:5256\u201367. https:\/\/doi.org\/10.4049\/jimmunol.1302079.","journal-title":"J Immunol"},{"key":"914_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0130","author":"Y Hou","year":"2021","unstructured":"Hou Y, Liang HL, Yu X, et al. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity. Sci Transl Med. 2021. https:\/\/doi.org\/10.1126\/scitranslmed.abb0130.","journal-title":"Sci Transl Med"},{"key":"914_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1158\/0008-5472.CAN-20-2339","volume":"81","author":"J Steenbrugge","year":"2021","unstructured":"Steenbrugge J, De Jaeghere EA, Meyer E, et al. Splenic hematopoietic and stromal cells in cancer progression. Cancer Res. 2021;81:27\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2339.","journal-title":"Cancer Res"},{"key":"914_CR61","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1002\/cam4.4818","volume":"11","author":"LS Xiao","year":"2022","unstructured":"Xiao LS, Hu CY, Cui H, et al. Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors. Cancer Med. 2022;11:4880\u20138. https:\/\/doi.org\/10.1002\/cam4.4818.","journal-title":"Cancer Med"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00914-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:30:52Z","timestamp":1781829052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00914-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00914-y","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies involving human tissues strictly adhered to the Declaration of Helsinki and were approved by the Ethics Committee of The First People\u2019s Hospital of Foshan, which operates according to the Declaration\u2019s principles. The ethical approval no. is FSYYY-EC-2022-79-1 with an approval date of 28 July 2022. Written informed consent was obtained from all participating volunteers. All experimental procedures involving animals were reviewed and approved by the Animal Care Committee of Guangdong Medical Laboratory Animal Center (GDMLAC) with ethical approval protocol number C202308-4 with an approval date of 4 August 2023. The Ethics Committee acts in accordance with the ethical guidelines for animal research established by the International Council for Laboratory Animal Science (ICLAS). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}